why Amicus Therapeutics Inc [FOLD] is a Good Choice for Investors After New Price Target of $16.20
Amicus Therapeutics Inc [NASDAQ: FOLD] gained 0.53% or 4889994.34 points to close at $4890000.0 with a heavy trading volume of 4149292 shares. It opened the trading session at $5.7, the shares rose to $5.7799 and dropped to $5.56, the range by which the price of